Company Description
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry.
It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.
The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; perishable (non-pharma) client packaging; technical services; and advanced monitoring sentry technology.
The company was founded in 2006 and is headquartered in Spring Branch, Texas.
| Country | United States |
| Founded | 2007 |
| IPO Date | Feb 5, 2025 |
| Industry | Integrated Freight & Logistics |
| Sector | Industrials |
| Employees | 38 |
| CEO | Wayne Williams |
Contact Details
Address: 244 Flightline Drive Spring Branch, Texas 78070-6241 United States | |
| Phone | 830 438 0395 |
| Website | callanjmb.com |
Stock Details
| Ticker Symbol | CJMB |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 2032545 |
| CUSIP Number | 131100109 |
| ISIN Number | US1311001093 |
| Employer ID | 99-0931141 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Wayne Williams | Founder, Chief Executive Officer, President and Chairman |
| Eric L. Kash | Executive Vice President and Director |
| Dr. David J. Croyle M.D. | Chief Medical Officer |
| Christopher Shields | Interim Chief Financial Officer, Senior Vice President of Emergency Preparedness and Response/Gov Affairs and Chief Operating Officer |
| Wiliam McBride | Chief Information Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 31, 2025 | 8-K | Current Report |
| Dec 8, 2025 | 8-K | Current Report |
| Dec 8, 2025 | DEF 14A | Other definitive proxy statements |
| Dec 5, 2025 | 8-K | Current Report |
| Nov 28, 2025 | PRE 14A | Other preliminary proxy statements |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 14, 2025 | 8-K | Current Report |
| Oct 3, 2025 | DEF 14C | Filing |
| Sep 24, 2025 | 424B3 | Prospectus |
| Sep 23, 2025 | PRE 14C | Filing |